The Ca-antagonist nifedipine reduces purine nucleoside and oxypurine release from ischemic heart.
D000227:Adenine Nucleotides / Q000378:metabolism; D000818:Animals; D003326:Coronary Circulation; D003327:Coronary Disease / Q000378:metabolism*; D006321:Heart / Q000187:drug effects; D019271:Hypoxanthine; D007042:Hypoxanthines / Q000378:metabolism; D066298:In Vitro Techniques; D007288:Inosine / Q000378:metabolism; D007700:Kinetics; D009206:Myocardium / Q000378:metabolism*; D009543:Nifedipine / Q000494:pharmacology*; D011684:Purine Nucleosides / Q000378:metabolism*; D051381:Rats; D019820:Xanthine; D014970:Xanthines / Q000378:metabolism
D000227:Adenine Nucleotides; D007042:Hypoxanthines; D011684:Purine Nucleosides; D014970:Xanthines; D019820:Xanthine; D019271:Hypoxanthine; D007288:Inosine; D009543:Nifedipine